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Abstract
Plasmodium vivax malaria is a neglected disease, particularly during pregnancy. Severe
vivax malaria is associated with inflammatory responses but in pregnancy immune alter-
ations make it uncertain as to what cytokine signatures predominate, and how the type and
quantity of blood immune mediators influence delivery outcomes. We measured the plasma
concentrations of a set of thirty-one biomarkers, comprising cytokines, chemokines and
growth factors, in 987 plasma samples from a cohort of 572 pregnant women from five
malaria-endemic tropical countries and related these concentrations to delivery outcomes
(birth weight and hemoglobin levels) and malaria infection. Samples were collected at
recruitment (first antenatal visit) and at delivery (periphery, cord and placenta). At recruit-
ment, we found that P. vivax–infected pregnant women had higher plasma concentrations
of proinflammatory (IL-6, IL-1β, CCL4, CCL2, CXCL10) and TH1-related cytokines (mainly
IL-12) than uninfected women. This biomarker signature was essentially lost at delivery and
was not associated with birth weight nor hemoglobin levels. Antiinflammatory cytokines (IL-
10) were positively associated with infection and poor delivery outcomes. CCL11 was the
only biomarker to show a negative association with P. vivax infection and its concentration
at recruitment was positively associated with hemoglobin levels at delivery. Birth weight was
negatively associated with peripheral IL-4 levels at delivery. Our multi-biomarker multicenter
study is the first comprehensive one to characterize the immunological signature of P. vivax
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infection in pregnancy thus far. In conclusion, data show that while TH1 and pro-inflamma-
tory responses are dominant during P. vivax infection in pregnancy, antiinflammatory cyto-
kines may compensate excessive inflammation avoiding poor delivery outcomes, and
skewness toward a TH2 response may trigger worse delivery outcomes. CCL11, a chemo-
kine largely neglected in the field of malaria, emerges as an important marker of exposure or
mediator in this condition.
Author summary
Cytokine and growth factor plasma concentrations were evaluated in women from five
countries endemic for malaria vivax, at different moments and blood compartments dur-
ing pregnancy. P. vivax infection during pregnancy was associated with a pro-inflamma-
tory and TH1 response, together with an antiinflammatory response. Nevertheless, at
delivery most associations between cytokines and infection were lost. Of note, CCL11/
eotaxin, a chemokine not generally analyzed in malaria studies, presented a lower concen-
tration in P. vivax-infected women and a protective association with hemoglobin levels at
delivery. Moreover, IL-4 levels had a negative association with birth weight. Data suggest
that a compensated inflammatory/antiinflammatory response in P. vivax infection during
pregnancy might avoid poor delivery outcomes, while a predominance of TH2 responses
may be detrimental for birth weight. Further research is warranted to unravel the role of
CCL11 in malaria infection or exposure.
Introduction
Malaria caused by Plasmodium vivax (Pv) is a neglected tropical disease, especially during
pregnancy, of worldwide distribution [1]. The negative effects of malaria in pregnant women
and their offspring have been better described for malaria caused by P. falciparum (Pf) whereas
fewer reports have investigated the outcomes of Pv infection in pregnancy [2]. To address this
gap, we performed a multicenter cohort study (the PregVax project) to characterize the burden
and health consequences of malaria caused by Pv in pregnant women from five malaria
endemic areas [3]. Within that cohort, we set out to characterize in more depth and breadth
the immune responses induced in pregnant women when infected or exposed to Plasmodium
parasites [4–7], and how they might correlate with negative clinical outcomes.
As part of this investigation, here we aim to better understand the cellular immune media-
tors circulating in the blood of pregnant women, whose immune system is altered due to preg-
nancy [8] when facing a parasite infection like Pv that has been associated to inflammation,
particularly in the case of severe disease [9]. A recent study by Singh et al [10] has shown
increased levels of inflammatory markers in vivax malaria during pregnancy, but it only
included three cytokines (IL-6, IL-1β and TNF). For a more comprehensive evaluation of the
multiple effects that Pv infection may elicit in the immune system of pregnant women, a wider
set of cellular biomarkers of different functions, including chemokines and growth factors as
well as T helper (TH)-related and regulatory cytokines, needs to be studied. This is particularly
relevant to further understand the role of CCL11 during pregnancy and its association with Pv
infection, as we previously showed decreased blood concentrations of this chemokine in preg-
nant women compared to non-pregnant individuals and in malaria-exposed compared to
malaria-naïve individuals [7].
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In an initial recent analysis, we evaluated the effect of pregnancy and of residing in tropical
countries, where exposure to infectious diseases is more common, on the concentration of
cytokines in plasma samples from women at different times during gestation and after puerpe-
rium, as well as in the three blood compartments (periphery, cord, placenta) [8]. We found
that the concentrations of circulating cytokines were the highest at postpartum (at least 10
weeks after delivery), with higher values at delivery compared to the first antenatal clinic visit.
Furthermore, anti-plasmodial antibodies (markers of malaria exposure) correlated with cyto-
kine concentrations postpartum, but not during pregnancy, suggesting that pregnancy had a
greater effect than malaria exposure on cytokine levels. Additionally, no strong associations
between cytokines and gestational age were detected.
In the present study, we assess the relationships between cytokine, chemokine and growth
factor plasma concentrations, delivery outcomes and presence of Pv, in the PregVax cohort.
Our multi-biomarker multicenter study is the first one to characterize the immunological sig-
nature of Pv infection in pregnancy to this extent.
Materials and methods
Study design and population
This analysis was done in the context of the PregVax project, a cohort study of 9,388 pregnant
women from five countries where malaria is endemic: Brazil (BR), Colombia (CO), Guatemala
(GT), India (IN) and Papua New Guinea (PNG), enrolled between 2008 and 2012 at the first
antenatal visit, and followed up until delivery. A venous blood sample was collected to perform
immunological assays in the following participants: a) any women with Pv infection (with or
without Plasmodium coinfections) at any visit from any country, b) a random subcohort
(approximately 10% of total cohort) assigned as the immunology cohort, at enrolment and
delivery. Bleedings at delivery included peripheral, cord and placental (only CO and PNG)
blood.
Pv and Pf (studied as a possible confounder in co-infected women) parasitaemias were
assessed at every visit in Giemsa-stained blood slides that were read onsite. An external valida-
tion of parasitemia results was performed by expert microscopists in a subsample of slides (100
per country) at the Hospital Clinic and at the Hospital Sant Joan de Deu in Barcelona, Spain.
Submicroscopic Pv and Pf infections were also determined at enrolment and delivery by real
time-PCR in a group of participants, which included the immunological subcohort. Malaria
symptoms and hemoglobin (Hb, g/dL) levels were also recorded at enrolment and delivery, as
well as neonatal birth weight (g).
The protocol was approved by the national and/or local ethics committees of each site, the
CDC IRB (USA) and the Hospital Clinic Ethics Review Committee (Barcelona, Spain). Writ-
ten informed consent was obtained from all study participants. All human subjects were
adults.
Isolation of plasma
Five to 10 mL of blood were collected aseptically in heparinized tubes. Plasma was separated
by centrifuging at 600 g for 10 min at room temperature, aliquoted and stored at -80ºC. Sam-
ples from BR, CO, GT and PNG were shipped to the Barcelona Institute for Global Health on
dry ice. The measurement of cytokines, chemokines and growth factors (hereinafter together
referred to as biomarkers) was performed at ISGlobal, Barcelona (Spain) to minimize inter-
site variability. Samples from India were analyzed at ICGEB, Delhi.
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Multiplex bead array assay
The biomarkers were analyzed in thawed plasmas with a multiplex suspension detection sys-
tem Cytokine Magnetic 30-Plex Panel (Invitrogen, Madrid, Spain) which allows the detection
of the following biomarkers: epidermal growth factor (EGF), Eotaxin/CCL11, fibroblast
growth factor (FGF), granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage
colony-stimulating factor (GM-CSF), hepatocyte growth factor (HGF), interferon (IFN)-α,
IFN-γ, interleukin (IL)-1RA, IL-1β, IL-2, IL-2R, IL-4, IL-5, IL-6, IL-7, IL-8/CXCL8, IL-10, IL-
12(p40/p70), IL-13, IL-15, IL-17, IFN-γ induced protein (IP-10/CXCL10), monocyte chemoat-
tractant protein (MCP-1/CCL2), monokine induced by IFN-γ (MIG/CXCL9), macrophage
inflammatory protein (MIP)-1α/CCL3, MIP-1β/CCL4, regulated on activation, normal T cell
expressed and secreted (RANTES/CCL5), tumor necrosis factor (TNF), and vascular endothe-
lial growth factor (VEGF). Fifty μL of the plasmas were tested in single replicates (dilution 1:2,
as recommended by the vendor). Each plate contained serial dilutions (1:3) of a standard sam-
ple of known concentration of each analyte provided by the manufacturer, as well as a blank
control and a reference sample control for quality control purposes, all of them in duplicates.
Upper and lower values of the standard curves for each analyte are displayed in S1 Table.
The assays were carried out according to the manufacturer’s instructions. Beads were
acquired on the BioPlex100 system (Bio-Rad, Hercules, CA) and concentrations calculated
using the Bioplex software. When values were out of range (OOR) according to the software, a
value three-times lower than the lowest standard concentration was assigned (as standard dilu-
tions were 1:3) for OOR values under the curves, and a value three-times higher than the high-
est standard concentration was assigned for OOR values above the curve. Moreover, the
software extrapolated values below and above the lower and higher concentrations, respec-
tively, of the standard curves when they fitted into the curves and were not OOR. These values
were kept with the exception of those three-times below the lowest standard concentration
and three-times above the highest standard concentration, for which those respective values
were assigned.
In addition, the cytokine TGF-β1 was analyzed in all plasmas except those from India, with
a DuoSet ELISA kit (R&D Systems). Following the vendor’s recommendations, latent TGF-β1
was activated to its immunoreactive form with HCl and neutralized with NaOH/HEPES. A
40-fold plasma dilution was used.
Plasmodium spp. detection by real time-PCR
From the whole cohort (9,388 women), 1500 recruitment and 1500 different delivery samples
were randomly selected for PCR. Samples from BR, CO, GT, and half of the samples from
PNG, were analyzed at the Istituto Superiore di Sanità (Rome, Italy), as described [3]. The
threshold for positivity for each species was established as a cycle threshold <45, according to
negative controls. Pv diagnosis for IN samples was performed in Delhi following Rome’s pro-
tocol adapted for the instrument sensitivity (the third step amplification 72ºC for 25 sec
instead of 5 sec). Approximately half of the PNG samples were analyzed for submicroscopic
infections in Madang, following a protocol [11] similar to that from Rome, except that the
threshold for positivity for each species was established as cycle threshold <40, according to
negative controls. DNA was extracted from whole blood-spot filter paper.
Sample selection and statistical methods
It was not possible to measure the biomarkers in all the plasma samples available due to budget
constraints. Therefore, an initial 50 enrolment samples per country (35 in IN, 235 total) and
their paired delivery samples were randomly selected. However, follow-up rates were low and
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when paired recruitment/delivery samples available were<50, random delivery samples were
included to achieve N = 50 (35 in IN). Thus, 129/235 delivery samples were paired to recruit-
ment samples. In addition, because malaria prevalence was generally low in our random sub-
set, we performed a case-control selection including all the available samples from women
with a Pv infection (diagnosed by microscopy and/or PCR) at recruitment (N = 49) or delivery
(N = 18) and similar numbers of randomly-selected samples with a negative Pv PCR result,
matched by country (N = 62 and N = 7 respectively). Finally, 144 placental plasmas, 125
peripheral plasmas collected at delivery and paired to the placental samples and 112 cord plas-
mas were analysed. A flow chart with all samples analysed is provided in S1 Fig. Data from the
5 countries were combined in the analysis. Except when otherwise specified, Pv infection was
defined as either a positive smear or a PCR positive result (or both).
Overall, our aim was to search for the associations between cytokine concentrations and
health outcomes (malaria infection, Hb levels and birth weight). In this regard, we performed
two separate investigations. First, a cross-sectional analysis in which health outcomes and cyto-
kine concentrations were examined at the same timepoint, either recruitment or delivery. Sec-
ond, a longitudinal analysis of the effect of cytokine concentrations at recruitment on health
outcomes at delivery.
To study the association of biomarkers with Pv infection, first a principal component analy-
sis (PCA) was performed. In the PCA, a large set of possibly correlated variables (e.g. cyto-
kines) is transformed into a small set of linearly uncorrelated variables called principal
components (PC), which may be interpreted as clusters of cytokines. For each PC, we show
the contribution (loading score) of each cytokine, considering the generally accepted cut-off
established at loading score = 0.3. For further analyses, we only considered the seven PCs that
accounted more for the variance of the data set (Eigenvalue�1, Kaiser-Guttman criterion). To
use PCs as variables (each representing several cytokines at a time), PC scores were predicted
for each subject and logistic regression models were estimated with PCs as independent vari-
ables and Pv infection as the dependent variable. We excluded TGF-β from the PCA analysis
as this cytokine was analyzed by a different technique (ELISA) and was not measured in IN.
Finally, to assess if our data set was suitable for PCA, we ran the Kaiser-Meyer-Olkin (kmo)
test for sampling adequacy.
To assess the association between individual biomarker concentrations and Pv infection, we
used the Mann-Whitney test in the crude analysis (corrected for multiple comparisons with the
Benjamini-Hochberg method) and estimated multivariable logistic regression models adjusting
for the following variables: site, age at recruitment, gestational age, parity, delivery mode (vagi-
nal vs caesarean birth) for the analysis with cytokine concentration at delivery and Pf infection.
At delivery, three different blood compartments were investigated: periphery, placenta and
cord. For this objective, pairwise statistical significance was interpreted based on 95% confi-
dence intervals (CI), and considered significant when the interval did not include 1. The same
adjusted regression model was estimated to analyze the association between peripheral plasma
biomarker concentration at recruitment and future (at delivery) Pv infection. Furthermore, the
association of biomarkers with submicroscopic and microscopic Pv infections was assessed with
linear regression models adjusted by site. Finally, the association between biomarker concentra-
tions in plasma with maternal Hb levels and birth weight was assessed using multivariable linear
regression models, adjusted for site, age (at recruitment), Hb levels (at recruitment), parity,
delivery mode for the analysis with cytokine concentration at delivery, Pv and Pf infection dur-
ing pregnancy. For this objective, pairwise statistical significance was interpreted based on 95%
confidence intervals, and considered significant when the interval did not include 0.
Overall, significance was defined at p<0.05. Analyses and graphs were performed using
Stata/SE 10.1 (College Station, TX, USA) and GraphPad Prism (La Jolla, CA, USA).
PLOS NEGLECTED TROPICAL DISEASES Cytokines and Plasmodium vivax infection during pregnancy
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008155 May 4, 2020 5 / 17
Results
Characteristics of the study population
A total of 987 plasma samples belonging to 572 pregnant women were analyzed for biomarker
concentration, comprising 346 peripheral plasma samples collected at recruitment, 385
peripheral plasmas at delivery, 112 cord plasmas and 144 placental plasmas. Unfortunately,
only 129 samples were paired between recruitment and delivery due to low follow-up rates.
The study population characteristics at baseline are provided in Table 1. The number of infec-
tion cases by country, method and timepoint are provided in S2 Table.
Association of Pv infection with plasma biomarker concentration at
recruitment
Considering the large amount of cytokine variables, we first performed a PCA to reduce the
dimensionality of data. The kmo test for sampling adequacy to PCA analysis resulted in
kmo = 0.85 that according to the literature might be considered as meritorious [12]. In the
PCA analysis, seven PCs contributed mostly to the variance of the data (S3 Table) and were
further considered for regression analyses. Of those seven PCs, three had a positive association
with Pv infection: PC3, PC5 and PC7 (S4 Table). Then we analyzed which cytokines contrib-
uted mostly to those PCs associated with Pv infection (Table 2). The PC3-proinflammatory-












Age (years)a,b 23.3 (6.0) [90] 22.3 (5.8) [115] 25.0 (7.7) [91] 23.5 (3.5) [58] 25.5 (5.7) [210]
Gravidity (number of previous pregnancies)d 0 26 (29%) 34 (30%) 30 (33%) 27 (47%) 69 (38%)
1–3 42 (47%) 56 (49%) 31 (34%) 29 (50%) 76 (42%)
4+ 22 (24%) 25 (21%) 30 (33%) 2 (3%) 37 (20%)
GA at recruitment
(weeks)d
0–12 15 (17%) 28 (24%) 5 (6%) 1 (2%) 11 (6%)
13–24 30 (34%) 42 (37%) 32 (36%) 30 (52%) 87 (48%)
25+ 43 (49%) 45 (39%) 52 (58%) 27 (47%) 84 (46%)
GA at delivery (weeks, by Ballard method)d 0–37 5 (8%) 29 (39%) 6 (10%) 29 (69%) 49 (33%)
38–41 54 (92%) 42 (57%) 35 (58%) 13 (31%) 83 (56%)
42+ 0 (0%) 3 (4%) 19 (32%) 0 (0%) 16 (11%)
BMI (kg/m2) a,b 25.7 (4.4) [89] 23.5 (3.5) [114] 25.8 (3.9) [91] 23.1 (4.5) [58] 23.7 (3.3) [173]
Hemoglobin (g/dL)a,b 11.3 (1.3) [90] 10.9 (1.6) [114] 11.1 (1.5) [82] 9.5 (1.6) [58] 9.52 (1.5) [214]
Birth weight a,g (g) 3166.1 (526.4) [61] 3224.11 (408.7) [82] 3151.9.6 (537.3) [60] 3031.7 (436.5) [42] 2923.1 (493.3) [159]
Delivery moded V 52 (79) 66 (82) 44 (71) 34 (79) 135 (100)
C 14 (21) 15 (18) 18 (29) 9 (21) 0 (0)
Syphilis screeningd POS 0 (0) 7 (10) N/A 0 (0) 5 (4)
NEG 56 (100) 64 (90) N/A 13 (100) 123 (96)





f Fisher’s exact test.
g birth weight excluding twins. PNG: Papua New Guinea. GA: gestational age (weeks). BMI: body mass index. V: vaginal. C: cesarean section. POS: positive. NEG:
negative. N/A: not available.
https://doi.org/10.1371/journal.pntd.0008155.t001
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chemokine group showed the highest contribution by CXCL8, CCL4 and CCL3. The PC5-an-
tiinflammatory-inflammatory group had the highest contribution by IL-10, CXCL10, IL-6 and
CCL2, whereas the PC7-CCL5-TH group had the highest contribution by CCL5, IL-4, IL-2R
and IL-12 (Table 2).
As the PCA is quite exploratory, we also analyzed biomarkers individually. We found that
Pv–infected women had higher plasma concentrations of proinflammatory biomarkers IL-6,
CXCL8, CCL3, CCL4 and CCL2, of TH1-related cytokines IL-12, IL-15 and IL-2R, and of
growth factor VEGF (Fig 1) than uninfected women, consistent with PCA analysis. After
adjusting for other confounders (see materials and methods), we found a positive association
of Pv infection with proinflammatory biomarkers IL-6, IL-1β, CCL4, CCL2, CXCL10 and TNF
(borderline non-significant for the latter); the antiinflammatory IL-10; the chemokine CCL5;
the TH1-related cytokines IL-12 and IL-2R; the TH2-related cytokine IL-5; and the growth fac-
tors FGF, HGF, VEGF and IL-7 (Table 3). In contrast, a negative association was observed
with CCL11 plasma concentration (Table 3).
Table 2. Loading scores for principal component analysis at recruitment.































Loading scores for each principal component (PC) with Eigenvalue>1 and proportion of unexplained variance after varimax rotation. In bold the PC with a positive
association with P. vivax infection. Only shown if loading score >0.3.
https://doi.org/10.1371/journal.pntd.0008155.t002
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Finally, we investigated the different effect (if any) of submicroscopic and microscopic Pv
infections, i.e. infection density, on biomarker plasma concentration at recruitment. Results
were interpreted based on 95% CI. On the one hand, Pv microscopic but not submicroscopic
infections were associated with elevated plasma concentrations of proinflammatory biomark-
ers TNF, IL-1β, IL-6, CXCL8, CCL2, CXCL10, CXCL9; the antiinflammatory IL-10 and IL-
1RA; the chemokine CCL5; the TH1-related cytokine IL-2R; the TH2-related cytokine IL-5; the
TH17-related cytokine IL-17 and the growth factors VEGF and GM-CSF (Table 4). On the
other hand, Pv submicroscopic but not microscopic infections were associated with elevated
plasma concentrations of biomarkers IL-2, FGF and IL-7 (Table 4). Of note, when we did this
stratification, the negative association with CCL11 levels was lost (Table 4).
Association of Pv infection with plasma biomarker concentration at
delivery
In PCA analysis at delivery, seven PCs also resulted in eigenvalue>1 (kmo = 0.86, S5 Table).
However, regression models showed no association of any PC with Pv infection at delivery (S6
Table). We did not observe differences between Pv-infected and uninfected women in plasma
biomarker levels in the crude analysis (not shown) at any compartment. In the adjusted analy-
sis, we observed a positive association of Pv infection with IFN-α and IL-12 peripheral plasma
concentration and with IL-10 placental plasma concentration (Table 3). After stratifying by
Fig 1. Effect of Plasmodium vivax infection on peripheral plasma biomarker concentrations at recruitment. Box plots represent median (white line), and 25th
and 75th percentiles (lower and upper hinge respectively) of biomarker concentrations in peripheral plasma at recruitment, in P. vivax infected (I, N = 54) and
uninfected (U, N = 247) pregnant women. Concentrations for all biomarkers are expressed in pg/mL. P-value corresponds to the Mann-Whitney test corrected for
multiple comparisons with the Benjamini-Hochberg method. �p<0.05, ��p<0.01, ���p<0.001.
https://doi.org/10.1371/journal.pntd.0008155.g001
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Plasmodium infection density, submicroscopic infection was associated with increased periph-
eral concentrations of IFN-α and decreased concentrations of IL-6, while microscopic infec-
tions were associated with elevated levels of TNF, IL-10 and IL-5. Moreover, microscopic
infections were associated with increased concentrations of TNF and IL-5 (Table 4).
Plasma biomarker concentration and delivery outcomes
Hb levels at delivery were positively associated with CCL11 and FGF peripheral plasma con-
centrations at recruitment (Table 5) and with CXCL9 placental plasma concentration
Table 3. Association of plasma biomarker concentration with P. vivax infection.
Recruitment Delivery
Periphery Periphery Placenta Cord
OR 95%CI OR 95%CI OR 95%CI OR 95%CI
TNF 1.03 1.00; 1.06 1.00 0.88; 1.12 1.02 0.89; 1.18 1.02 0.97; 1.08
IL-1β 1.06 1.02; 1.09 1.00 0.89; 1.13 1.06 0.93; 1.21 1.00 0.95; 1.05
IL-6 1.09 1.03; 1.15 0.96 0.87; 1.05 0.91 0.81; 1.04 1.04 0.98; 1.10
IL-10 1.09 1.02; 1.17 0.97 0.86; 1.09 1.17 1.02; 1.34 1.06 0.54; 2.07
IL-1RA 1.06 0.98; 1.15 1.06 0.97; 1.16 1.04 0.94; 1.16 1.11 0.94; 1.30
TGF-β 1.01 0.88; 1.17 1.20 0.97; 1.47 1.01 0.87; 1.16 0.91 0.79; 1.06
IFN-α 1.05 0.93; 1.19 1.33 1.11; 1.58 1.09 0.94; 1.26 1.15 0.78; 1.70
CXCL8 1.02 0.98; 1.07 1.03 0.98; 1.08 0.99 0.92; 1.08 1.05 1.00; 1.11
CCL3 1.04 0.95; 1.13 1.08 0.94; 1.24 0.89 0.74; 1.07 1.06 0.87; 1.28
CCL4 1.09 1.02; 1.17 0.90 0.77; 1.04 1.01 0.91; 1.12 1.06 0.98; 1.15
CCL2 1.24 1.10; 1.41 1.01 0.93; 1.09 1.06 0.97; 1.16 1.07 0.99; 1.16
CXCL10 1.17 1.06; 1.29 1.04 0.91; 1.18 0.93 0.79; 1.09 0.97 0.82; 1.13
CXCL9 1.06 0.97; 1.15 1.03 0.94; 1.14 1.05 0.92; 1.19 1.01 0.92; 1.12
CCL11 0.88 0.77; 0.99 1.01 0.87; 1.18 0.93 0.80; 1.09 0.91 0.76; 1.08
CCL5 1.13 1.01; 1.27 1.08 0.93; 1.26 0.93 0.84; 1.02 1.01 0.84; 1.22
IFN-γ 1.16 0.84; 1.59 1.38 0.89; 2.14 1.00 N/A 0.56 0.01; 36.96
IL-12 1.37 1.11; 1.68 1.57 1.15; 2.15 0.97 0.77; 1.23 0.84 0.60; 1.18
IL-2 1.04 0.97; 1.11 0.98 0.89; 1.09 1.06 0.96; 1.17 1.03 0.95; 1.11
IL-15 1.03 0.98; 1.08 1.03 0.91; 1.16 1.05 0.93; 1.20 0.97 0.83; 1.13
IL-2R 1.12 1.02; 1.24 0.99 0.87; 1.14 0.91 0.75; 1.09 0.94 0.76; 1.15
IL-4 0.94 0.73; 1.22 1.04 0.83; 1.31 0.92 0.52; 1.64 0.69 0.06; 8.61
IL-5 1.04 1.01; 1.08 1.00 0.91; 1.11 1.15 0.87; 1.51 1.00 0.95; 1.06
IL-13 1.10 0.99; 1.22 0.98 0.86; 1.12 0.91 0.70; 1.19 0.84 0.57; 1.22
IL-17 1.03 0.99; 1.07 1.10 0.91; 1.33 0.75 0.22; 2.53 1.01 0.93; 1.10
EGF 0.98 0.89; 1.08 0.96 0.85; 1.09 1.04 0.90; 1.20 0.97 0.81; 1.16
FGF 1.08 1.02; 1.14 0.93 0.85; 1.03 1.08 0.97; 1.19 1.03 0.93; 1.13
HGF 1.06 1.01; 1.10 0.96 0.90; 1.03 1.00 0.94; 1.06 1.05 0.93; 1.20
VEGF 1.09 1.02; 1.17 0.97 0.84; 1.12 1.05 0.89; 1.23 1.05 0.92; 1.19
G-CSF 1.10 0.88; 1.36 1.03 0.74; 1.43 0.96 0.75; 1.24 1.06 0.88; 1.29
GM-CSF 1.02 0.99; 1.06 1.04 0.97; 1.11 1.09 0.98; 1.21 1.00 0.95; 1.05
IL-7 1.05 1.01; 1.08 0.97 0.88; 1.07 0.99 0.84; 1.16 1.03 0.91; 1.17
Multivariable logistic regression models adjusting for the following variables: site, age at recruitment, gestational age, parity, delivery mode (just for delivery samples)
and P. falciparum infection were estimated. P. vivax infection cases included those diagnosed by either PCR or microscopy. Odds ratio (OR) per 25% increase in
biomarker concentration. Recruitment, N = 275; delivery periphery, N = 199 (infection rates by Plasmodium spp. and timepoint in S2 Table). Placenta N = 75 (61 Pv-, 14
Pv+). Cord N = 82 (57 Pv- 25 Pv+). In bold if 95% confidence interval (CI) does not include 1. N/A: regression model could not be estimated as all samples considered
have the same value for IFN-γ concentration (9.6 pg/mL).
https://doi.org/10.1371/journal.pntd.0008155.t003
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(Table 6), and negatively associated with IL-1RA and G-CSF cord plasma concentrations
(Table 6). Birth weight showed no association with any biomarker at recruitment (Table 5),
and it was negatively associated with peripheral IL-4 concentration at delivery (Table 6).
Discussion
We report an exhaustive profiling of plasma biomarkers including cytokines, chemokines and
growth factors in malaria in pregnancy caused by Pv, and their association with poor delivery
outcomes. We separated the analysis of samples obtained at the first antenatal visit from the
ones at delivery, as previous analyses in this cohort showed differences in most biomarker
Table 4. Association of plasma biomarker concentration with microscopic and submicroscopic P. vivax infection.
RECRUITMENT DELIVERY
Neg PCR+ Microscopy + Neg PCR+ Microscopy +
Effect Effect 95% CI Effect 95% CI Effect Effect 95% CI Effect 95% CI
TNF 0 0.94 -0.32; 2.20 1.53 0.17; 2.88 0 0.58 -0.14; 1.31 1.89 0.46; 3.32
IL-1β 0 1.31 -0.09; 2.71 2.98 1.48; 4.48 0 0.20 -0.50; 0.90 0.21 -1.18; 1.60
IL-6 0 0.30 -0.77; 1.36 1.89 0.75; 3.03 0 -0.68 -1.23; -0.13 0.29 -0.80; 1.38
IL-10 0 0.38 -0.37; 1.14 1.75 0.94; 2.56 0 -0.22 -0.71; 0.27 1.17 0.19; 2.14
IL-1RA 0 0.46 -0.19; 1.10 0.74 0.05; 1.43 0 0.17 -0.34; 0.68 0.07 -0.94; 1.08
TGF-β 0 -0.01 -0.44; 0.42 -0.05 -0.49; 0.39 0 0.04 -0.25; 0.32 0.26 -0.29; 0.81
IFN-α 0 0.26 -0.15; 0.68 0.21 -0.23; 0.65 0 0.34 0.03; 0.65 0.02 -0.60; 0.64
CXCL8 0 -0.14 -1.16; 0.88 1.18 0.09; 2.28 0 0.39 -0.67; 1.45 1.13 -0.98; 3.24
CCL3 0 0.65 0.04; 1.26 1.15 0.50; 1.81 0 -0.10 -0.48; 0.28 -0.16 -0.92; 0.59
CCL4 0 -0.01 -0.60; 0.57 0.31 -0.32; 0.93 0 -0.26 -0.68; 0.15 -0.66 -1.47; 0.16
CCL2 0 0.62 -0.25; 1.49 1.76 0.82; 2.69 0 -0.07 -0.63; 0.49 -0.20 -1.31; 0.92
CXCL10 0 0.36 -0.32; 1.04 1.07 0.34; 1.80 0 -0.1 -0.51; 0.32 0.03 -0.80; 0.85
CXCL9 0 0.19 -0.39; 0.78 0.67 0.04; 1.30 0 -0.21 -0.75; 0.33 0.36 -0.72; 1.43
CCL11 0 0.03 -0.43; 0.49 -0.43 -0.93; 0.06 0 -0.14 -0.53; 0.24 -0.14 -0.90; 0.63
CCL5 0 0.26 -0.19; 0.70 0.62 0.14; 1.10 0 0.04 -0.34; 0.42 0.46 -0.30; 1.22
IFN-γ 0 0.00 -0.17; 0.16 0.00 -0.18; 0.18 0 0.02 -0.17; 0.20 -0.10 -0.47; 0.27
IL-12 0 0.30 0.03; 0.57 0.38 0.09; 0.67 0 0.17 -0.04; 0.38 0.20 -0.21; 0.62
IL-2 0 0.75 0.08; 1.43 0.28 -0.45; 1.01 0 -0.14 -0.68; 0.39 -0.80 -1.85; 0.26
IL-15 0 0.76 0.12; 1.40 1.01 0.32; 1.70 0 0.14 -0.34; 0.63 -0.36 -1.33; 0.60
IL-2R 0 0.44 -0.10; 0.98 1.07 0.49; 1.65 0 0.03 -0.30; 0.35 0.13 -0.51; 0.77
IL-4 0 0.02 -0.17; 0.20 -0.05 -0.25; 0.15 0 -0.06 -0.32; 0.21 -0.16 -0.69; 0.37
IL-5 0 0.86 -0.42; 2.13 1.89 0.52; 3.26 0 0.02 -0.72; 0.76 1.68 0.21; 3.15
IL-13 0 -0.05 -0.62; 0.53 0.23 -0.38; 0.85 0 -0.05 -0.42; 0.32 -0.32 -1.05; 0.41
IL-17 0 0.55 -0.50; 1.60 1.28 0.16; 2.41 0 0.57 0.03; 1.12 -0.12 -1.20; 0.96
EGF 0 -0.26 -0.81; 0.28 -0.21 -0.79; 0.38 0 -0.28 -0.63; 0.08 -0.15 -0.85; 0.56
FGF 0 0.99 0.34; 1.64 0.59 -0.11; 1.28 0 -0.40 -0.93; 0.12 -0.32 -1.36; 0.72
HGF 0 0.90 -0.25; 2.04 0.17 -1.05; 1.39 0 -0.65 -1.38; 0.08 0.13 -1.26; 1.52
VEGF 0 0.07 -0.40; 0.55 0.98 0.48; 1.48 0 -0.36 -0.73; 0.01 -0.13 -0.87; 0.60
G-CSF 0 0.09 -0.18; 0.35 0.06 -0.22; 0.34 0 -0.09 -0.26; 0.08 0.13 -0.20; 0.47
GM-CSF 0 0.78 -0.46; 2.03 1.52 0.18; 2.86 0 0.39 -0.40; 1.18 -0.27 -1.81; 1.27
IL-7 0 1.58 0.32; 2.83 1.18 -0.17; 2.53 0 0.31 -0.52; 1.14 1.55 -0.06; 3.17
Multivariable logistic regression models adjusting for site. CI: confidence interval. Neg: no infection detected by either PCR or microscopy. PCR+: PCR positive and
microscopy negative. Microscopy +: smear positive regardless of PCR result. Expected change: change in mean concentration measured in pg/mL. Recruitment N = 76:
Neg N = 26; PCR+ N = 36; Microscopy + N = 14. Delivery N = 89: Neg N = 61; PCR+ N = 24; Microscopy+ N = 4. In bold if 95% CI does not include 0.
https://doi.org/10.1371/journal.pntd.0008155.t004
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concentrations between recruitment and delivery [8]. However, recruitment samples, which
were collected at first, second and third trimester of pregnancy, were not further categorized
because the correlation between women’s gestational age and biomarker concentration in
plasma was low in all cases in this cohort [8].
It is well known that Plasmodium spp. infection is accompanied by an inflammatory
response that seems to correlate with severity of malaria disease [9,13–18]. Also, placental
inflammation has been shown in Pf malaria in pregnancy and linked to poor delivery out-
comes [19–22]. However, the peripheral compartment in malaria during pregnancy has been
less well studied, especially for Pv malaria in pregnancy. Here we showed that, in pregnant
Table 5. Association of biomarkers at recruitment with hemoglobin levels at delivery and birth weight.
Hemoglobin (g/dL) Birth weight (g)
Effect 95% CI Effect 95% CI
TNF 0.01 -0.02; 0.05 -3.83 -11.40; 3.75
IL-1β 0.01 -0.03; 0.04 0.38 -7.23; 8.00
IL-6 -0.02 -0.07; 0.03 -8.75 -21.92; 4.41
IL-10 0.00 -0.06; 0.07 -16.00 -32.73; 0.73
IL-1RA 0.01 -0.06; 0.08 -3.38 -21.29; 14.53
TGF-β -0.08 -0.20; 0.04 -1.15 -32.95; 30.65
IFN-α -0.01 -0.12; 0.11 -24.09 -52.01; 3.82
CXCL8 0.01 -0.03; 0.06 -6.34 -16.67; 3.98
CCL3 0.00 -0.08; 0.09 -3.60 -24.23; 17.03
CCL4 0.02 -0.04; 0.08 -3.48 -18.15; 11.19
CCL2 0.03 -0.06; 0.13 1.47 -22.06; 25.00
CXCL10 -0.03 -0.12; 0.06 -15.18 -37.20; 6.85
CXCL9 -0.01 -0.09; 0.08 -6.56 -27.38; 14.25
CCL11 0.15 0.03; 0.26 -9.84 -38.48; 18.80
CCL5 0.00 -0.12; 0.11 1.41 -26.42; 29.23
IFN-γ -0.15 -0.49; 0.19 -50.53 -135.09; 34.03
IL-12 0.04 -0.17; 0.24 4.84 -44.48; 54.16
IL-2 0.05 -0.01; 0.11 12.87 -2.32; 28.06
IL-15 0.01 -0.06; 0.07 3.55 -12.91; 20.00
IL-2R -0.02 -0.11; 0.07 -7.58 -30.77; 15.60
IL-4 0.00 -0.18; 0.17 -18.35 -62.30; 25.59
IL-5 0.02 -0.02; 0.06 -4.17 -12.20; 3.87
IL-13 0.01 -0.08; 0.11 -3.97 -26.94; 19.00
IL-17 0.02 -0.02; 0.06 1.56 -7.41; 10.53
EGF 0.05 -0.02; 0.12 10.98 -6.24; 28.20
FGF 0.06 0.00; 0.12 3.26 -11.52; 18.04
HGF 0.01 -0.03; 0.05 -2.61 -12.52; 7.30
VEGF 0.00 -0.10; 0.11 -17.65 -35.44; 0.13
G-CSF 0.02 -0.02; 0.06 -6.24 -14.68; 2.20
GM-CSF -0.01 -0.19; 0.16 -13.46 -54.75; 27.84
IL-7 0.03 -0.01; 0.07 0.10 -8.52; 8.72
Multivariable linear regression models adjusting for the following variables: site, age at recruitment, hemoglobin
(Hb) at recruitment for analysis of Hb at delivery, gravidity, gestational age, delivery mode, and P. falciparum and P.
vivax infection. Effect: change in Hb levels (g/dL) or birth weight (g) per 25% increase in biomarker concentration.
N = 145. In bold if 95% confidence interval (CI) does not include 0.
https://doi.org/10.1371/journal.pntd.0008155.t005
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women at enrolment, Pv infection is associated with a broad proinflammatory response. First,
in the exploratory PCA analysis we showed that two of the three clusters of cytokines associ-
ated with Pv infection were mainly proinflammatory: the PC3, composed by CXCL8, CCL4
and CCL3; and the PC5, composed by CXCL10, IL-6, CCL2 and IL-10. In agreement with this,
the crude and adjusted analyses showed positive associations of IL-6, IL-1β, CXCL8, CCL3,
CCL4, CCL2 and CXCL10 with Pv infection. Pv microscopic but not submicroscopic infec-
tions accounted for this inflammatory response. Another study in India has recently shown
Table 6. Association of biomarkers at delivery with hemoglobin levels at delivery and birth weight.
. Periphery Placenta Cord
Hemoglobin Birth weight Hemoglobin Birth weight Hemoglobin Birth weight
Effect 95%CI Effect 95%CI Effect 95%CI Effect 95%CI Effect 95%CI Effect 95%CI
TNF 0.03 -0.04; 0.10 0.19 -18.88; 19.27 0.01 -0.15; 0.17 26.49 -6.86; 59.85 0.00 -0.05; 0.05 -4.84 -16.71; 7.03
IL-1β -0.03 -0.09; 0.03 -6.18 -23.11; 10.75 0.00 -0.15; 0.14 22.00 -1.36; 45.37 0.00 -0.04; 0.05 -0.26 -10.49; 9.97
IL-6 0.01 -0.04; 0.06 5.35 -7.69; 18.38 0.03 -0.03; 0.09 10.48 -1.89; 22.86 -0.03 -0.08; 0.02 -9.03 -20.49; 2.44
IL-10 -0.03 -0.10; 0.04 -14.67 -33.31; 3.97 0.11 -0.14; 0.36 26.79 -27.44; 81.03 -0.03 -0.71; 0.64 -9.31 -169.30; 150.69
IL-1RA -0.03 -0.09; 0.03 -7.08 -23.32; 9.17 0.10 -0.01; 0.21 10.36 -13.19; 33.90 -0.15 -0.29; -0.01 -25.49 -58.66; 7.68
TGF-β -0.02 -0.18; 0.13 -16.36 -58.59; 25.88 0.00 -0.10; 0.10 3.58 -17.84; 25.00 -0.06 -0.19; 0.07 11.11 -20.40; 42.62
IFN-α -0.02 -0.13; 0.08 -22.77 -50.47; 4.93 0.15 -0.05; 0.35 29.95 -11.01; 70.92 -0.05 -0.40; 0.31 4.66 -77.58; 86.89
CXCL8 0.00 -0.03; 0.03 0.69 -7.62; 8.99 0.03 -0.03; 0.08 8.70 -3.21; 20.60 -0.03 -0.08; 0.02 -9.25 -20.08; 1.57
CCL3 0.07 -0.01; 0.14 -6.41 -26.16; 13.34 0.07 -0.07; 0.22 22.50 -7.74; 52.74 -0.15 -0.32; 0.03 -4.51 -45.79; 36.77
CCL4 0.01 -0.06; 0.08 -0.73 -19.43; 17.97 0.00 -0.10; 0.10 10.83 -9.85; 31.50 -0.01 -0.08; 0.06 -13.29 -29.61; 3.03
CCL2 0.01 -0.04; 0.06 -1.50 -15.10; 12.09 0.04 -0.06; 0.14 6.60 -15.10; 28.30 -0.02 -0.09; 0.05 -11.58 -27.52; 4.35
CXCL10 0.05 -0.03; 0.13 14.89 -7.40; 37.18 0.08 0.00; 0.17 3.02 -15.73; 21.78 0.02 -0.11; 0.15 -17.21 -47.33; 12.91
CXCL9 0.02 -0.05; 0.08 2.32 -14.58; 19.21 0.09 0.01; 0.17 -0.86 -19.02; 17.30 -0.02 -0.11; 0.07 -7.02 -27.43; 13.39
CCL11 0.01 -0.08; 0.10 3.75 -20.49; 27.99 0.02 -0.13; 0.17 15.21 -17.60; 48.03 0.10 -0.06; 0.27 33.55 -4.87; 71.98
CCL5 -0.05 -0.15; 0.05 19.81 -5.78; 45.41 0.03 -0.06; 0.12 6.22 -14.02; 26.46 -0.04 -0.22; 0.14 16.95 -23.90; 57.81
IFN-γ 0.05 -0.15; 0.24 -8.66 -60.06; 42.75 -11.83 -62.25; 38.60 -1625.89 -1.3e+04; 9369.71 4.10 -0.39; 8.59 258.64 -857.77; 1375.05
IL-12 -0.02 -0.17; 0.13 -5.63 -44.85; 33.59 0.01 -0.17; 0.18 36.44 -1.27; 74.16 -0.01 -0.30; 0.29 -9.16 -78.97; 60.64
IL-2 -0.07 -0.13; -0.01 1.96 -13.98; 17.89 0.09 -0.05; 0.23 -7.16 -38.20; 23.88 0.00 -0.08; 0.08 12.17 -5.97; 30.31
IL-15 -0.06 -0.14; 0.02 6.61 -13.80; 27.02 0.09 -0.02; 0.20 6.93 -17.89; 31.75 0.02 -0.12; 0.15 -21.09 -52.08; 9.90
IL-2R -0.03 -0.13; 0.06 -10.66 -35.41; 14.09 0.15 -0.04; 0.34 13.51 -28.76; 55.79 -0.04 -0.23; 0.15 -11.77 -57.33; 33.79
IL-4 -0.02 -0.15; 0.11 -43.01 -76.74; -9.27 N/A regression model N/A regression model 2.56 -0.20; 5.33 2.56 -0.25; 5.36
IL-5 0.01 -0.05; 0.06 -9.12 -23.96; 5.72 -0.10 -0.31; 0.11 5.65 -40.90; 52.19 -0.02 -0.07; 0.03 5.30 -6.61; 17.21
IL-13 0.03 -0.04; 0.11 -17.75 -37.69; 2.19 0.01 -0.21; 0.24 -2.60 -51.12; 45.93 0.01 -0.33; 0.36 3.93 -76.19; 84.05
IL-17 -0.01 -0.12; 0.10 -22.26 -51.12; 6.59 0.18 -0.27; 0.63 60.09 -33.19; 153.37 0.04 -0.06; 0.14 -8.10 -31.69; 15.49
EGF -0.07 -0.15; 0.02 -5.31 -27.93; 17.32 0.08 -0.04; 0.21 1.85 -26.51; 30.20 -0.01 -0.18; 0.15 -18.33 -56.15; 19.48
FGF -0.04 -0.10; 0.02 5.93 -9.57; 21.43 0.05 -0.05; 0.15 -5.45 -27.93; 17.04 0.03 -0.08; 0.14 -6.93 -33.37; 19.51
HGF 0.00 -0.05; 0.04 -7.04 -19.74; 5.66 0.00 -0.06; 0.07 -1.62 -15.52; 12.27 -0.08 -0.20; 0.04 -20.29 -48.62; 8.04
VEGF -0.01 -0.09; 0.08 6.27 -16.05; 28.60 0.11 -0.01; 0.23 16.61 -9.45; 42.67 -0.08 -0.20; 0.03 -26.18 -52.87; 0.50
G-CSF -0.06 -0.21; 0.09 -21.01 -60.86; 18.84 0.06 -0.08; 0.20 20.24 -9.51; 49.98 -0.21 -0.37; -0.04 20.83 -19.02; 60.69
GM-CSF -0.01 -0.05; 0.04 -5.97 -18.69; 6.75 -0.03 -0.26; 0.20 31.96 -18.02; 81.94 0.01 -0.04; 0.06 3.61 -7.06; 14.28
IL-7 0.00 -0.05; 0.06 -3.19 -17.42; 11.04 -0.01 -0.15; 0.12 13.18 -15.61; 41.97 -0.04 -0.16; 0.08 -15.21 -42.00; 11.58
Multivariable linear regression models adjusting for the following variables: site, age at recruitment, hemoglobin (Hb) at recruitment for analysis of Hb at delivery, Hb at
delivery for analysis of birth weight (BW), gravidity, delivery mode, P. falciparum and P. vivax infection. Effect: change in Hb levels (mg/dL) or BW (g) per 25% increase
in biomarker concentration. Periphery N = 188; Placenta N = 75; Cord N = 81; In bold if 95% confidence interval (CI) does not include 0. All samples considered have
the same value for IL-4 concentration in plasma (pg/ml). N/A regression model: model could not be estimated as all samples considered have the same value for IL-4
concentration (38.96 pg/mL).
https://doi.org/10.1371/journal.pntd.0008155.t006
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that women with Pv malaria in pregnancy have more IL-6, TNF and IL-1β in peripheral
plasma than uninfected pregnant women [10].
However, all the above associations of infection with inflammation were lost at delivery. No
PCs and no individual proinflammatory biomarker showed any association with Pv infection
at delivery. Only microscopic infections at delivery showed a positive association with TNF
levels. We [8] and others [23,24] have shown that labor is accompanied by a peripheral proin-
flammatory response which may have masked any differences in inflammatory biomarker
concentrations between infected and uninfected women. Moreover, there is controversy about
Pv cytoadhesion to placenta but we have reported placental Pv monoinfections with no signs
of placental inflammation [25].
Despite the strong evidence of a potent inflammatory response triggered by Pv infection
during pregnancy, our results did not show an impact of inflammation at recruitment on
delivery outcomes. Moreover, in this cohort no poor delivery outcomes were attributed to Pv
infection during pregnancy, except for anemia in symptomatic Pv-infected women [3].
According to our data, we propose that an antiinflammatory response could be compensating
the excessive inflammation. Thus, IL-10 (antiinflammatory cytokine) clustered with CXCL10,
IL-6 and CCL2 (all proinflammatory biomarkers) in the PC5, which was associated with Pv
infection at recruitment. Moreover, we showed a positive association of Pv infection with
peripheral IL-10 concentration at recruitment, peripheral IL-10 at delivery (association only
with microscopic infections) and placental IL-10 concentration at delivery. In addition, cord
IL-1RA levels showed a negative association with Hb levels at delivery. Others have shown that
Pv infection induces a proinflammatory response associated with an immunomodulatory pro-
file mediated by IL-10 and TGF-β [17] and production of IL-10 and expansion of regulatory T
cells [26] in non-pregnant individuals.
We also studied TH-related biomarkers and found that while Pv infection was vaguely asso-
ciated with TH2-related IL-5, infection was consistently and positively associated with TH1
cytokines (but not IFN-γ) in the PCA analysis (where IL-12 clustered with IL-2R in the PC7),
as well as the crude and the adjusted analyses. Among them, the strongest association was
observed with IL-12 plasma concentration, the key cytokine in TH1 differentiation. Moreover,
CCL11, which has been associated to TH2-responses in allergic reactions and is able to recruit
TH2 lymphocytes [27], showed a negative association with Pv infection, supporting the
hypothesis that Pv malaria in pregnancy triggers a TH1 response. Elevated levels of IFN-γ have
been positively, negatively and not associated with placental Pf malaria (reviewed in [28]) and
the role of the TH1 arm in malaria-related poor delivery outcomes is also controversial [21,29].
According to our present and previous data, we propose that failing to mount a TH1
response might worsen delivery outcomes, as we showed here that TH2-type IL-4 peripheral
plasma concentration at delivery was negatively associated with birth weight, while previous
results of a flow cytometry analysis of PNG women in this cohort showed a protective role of
circulating TH1 cells (CD3
+-CD4+-IFN-γ+-IL-10-) with birth weight [6].
CCL11, a chemokine poorly studied in the context of malaria, was the only biomarker
among the 31 studied to show a negative association (OR<1) with Pv infection, although the
associations were lost when stratifying by infection density. We had previously shown that
non-pregnant women heavily exposed to malaria had lower levels of circulating CCL11 than
malaria-naïve controls [7]. Thus it seems that (low) CCL11 concentration could be used as a
marker of malaria infection/exposure. Our analysis supports this finding, as higher CCL11
plasma concentration at recruitment was associated with higher Hb levels at delivery, and we
had established previously that clinical Pv infection is associated with maternal anemia [3].
However, from this study we cannot determine whether this association is causative and/or
what role (if any) CCL11 has on Pv infection.
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Our study presents some limitations. Blood samples were collected in heparin vacutainers,
therefore we cannot rule out contamination of plasma by platelet-derived factors. Also, the
restricted number of samples with quantified parasitemia, the low concentration of some cyto-
kines, and the number of women who were lost to follow up, prevented us from performing
more detailed analyses on the relationship between certain cytokines and malaria prospec-
tively. Moreover, we did not collect information regarding important and prevalent infectious
diseases in some of the study sites, such as helminth infections. However, this may not be con-
sidered as a bias in the CCL11 analysis, as helminths would actually provoke an increase in
CCL11 while we observe a decrease in this chemokine associated to malaria.
In conclusion, data show that while TH1 and proinflammatory responses are dominant dur-
ing Pv infection in pregnancy, antiinflammatory cytokines may compensate excessive inflam-
mation avoiding poor delivery outcomes, and skewness towards a TH2 response may trigger
worse delivery outcomes. CCL11, a chemokine largely neglected in the field of malaria,
emerges as an important marker of exposure or mediator in this condition.
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